Loading organizations...
Key people at Amil.
Founded in 1978 by Edson de Godoy Bueno, São Paulo, Brazil-based Amil provides comprehensive health and dental insurance plans alongside operating a large proprietary network of hospitals, medical centers, and clinics. The company generates revenue through premium-based subscriptions from corporate employers, families, and individual clients seeking managed healthcare and direct medical services across the country. Operating at a massive national scale, the organization currently serves approximately 5.4 million health and dental beneficiaries, manages over 30 hospitals, and maintains a direct workforce of more than 20,000 employees. In December 2023, former parent company UnitedHealth Group agreed to sell the healthcare business to Brazilian entrepreneur José Seripieri Filho for approximately $2.2 billion, or 11 billion Brazilian Reais. This major acquisition subsequently received official regulatory approval in early 2024 from Brazil's antitrust regulator CADE and the National Supplementary Health Agency.
Key people at Amil.
Amil Participações S.A. (AMIL3) is a leading Brazilian healthcare company that provides comprehensive health plans, including medical, hospital, outpatient, and dental services, while owning and operating hospitals, maternity wards, emergency rooms, and diagnostic centers.[1][2] It serves individual, family, and corporate clients with services like hospital care, medical procedures, urgent care, clinical exams, and health research, positioning itself as a premium innovator in Brazil's health sector with products such as Amil One (exclusive premium plans), Amil Fácil (cost-effective regional plans), and Amil Dental (online-accessible dental coverage).[1][2][4][6]
Founded in 1978, Amil grew to become Latin America's largest healthcare company by combining operational expertise with a vast network of hospitals, clinics, and labs across Brazil, headquartered in Rio de Janeiro (with some references to São Paulo operations).[1][2][3][4] Formerly a subsidiary of UnitedHealth Group (acquired in 2012), it emphasizes innovation, transparency, and efficiency, driving sustainable relationships in the health ecosystem.[1][2][3][6]
Amil was founded in 1978 by Edson Bueno and Dulce Bueno in Rio de Janeiro, Brazil, starting as a health insurance startup amid growing demand for private healthcare.[1][2][3] The Bueno family built it into Brazil's top healthcare provider through decades of innovation and expansion; by 2007, Amil went public on the Brazilian stock exchange (B3: AMIL3), solidifying its market leadership.[3]
In 2012, UnitedHealth Group acquired a controlling stake in a landmark deal—the largest U.S. investment in a Brazilian company at the time—with Edson Bueno joining UHG's board.[1][2][3] This acquisition marked Amil's evolution from a family-led operator to a global-backed powerhouse, while the Bueno family later channeled their expertise into DNA Capital in 2013, investing in healthcare ventures worldwide.[3]
Amil rides Brazil's booming private healthcare trend, where public system gaps (SUS overload) drive demand for efficient, tech-enabled private plans amid aging populations and rising chronic diseases.[1][6] Its timing capitalized on 1970s liberalization of health insurance and 2010s digital health surge, with UnitedHealth's 2012 buyout accelerating tech integration like claims processing and telehealth precursors.[2][3][4]
Market forces favor Amil: regulatory support for innovation (ANS licensing), post-pandemic digital adoption, and economic shifts boosting corporate wellness spending.[4][6] It influences Brazil's ecosystem by setting premium standards, enabling family-backed spinouts like DNA Capital (now global VC/PE in health tech), and pioneering scalable models that blend traditional care with emerging tech like diagnostics and AI-driven personalization.[3][6]
Amil's trajectory points to deeper tech infusion—expanding telehealth, AI diagnostics, and data-driven plans amid Brazil's digital health boom and global partnerships post-UHG era.[4] Trends like value-based care, regulatory digitization, and LatAm expansion will shape it, potentially amplifying influence via DNA Capital's venture arm targeting health startups.[3][6]
As Latin America's healthcare pioneer, Amil remains poised to redefine accessible, innovative care, evolving from Bueno family vision to a tech-powered leader sustaining its ecosystem dominance.[1][3]
